Brief: Pharmiva Announces Information Memorandum In Relation To Rights Issue

Pharmiva AB (publ)

05/09/2022 12:03

Sept 5 (Reuters) - Pharmiva AB (publ)  PHARM.ST :
    * ANNOUNCED ON 15 AUG DECISION OF BOD TO CARRY OUT NEW ISSUE
OF
SHARES WITH PRE-EMPTIVE RIGHTS FOR EXISTING SHAREHOLDERS AND AT
THE SAME TIME DIRECTED ISSUE OF SHARES TO BE CARRIED OUT IN
PARALLEL WITH PRE-EMPTIVE ISSUE
    * ANNOUNCES INFORMATION MEMORANDUM IN RELATION TO COMPANY'S
FULLY
UNDERWRITTEN RIGHTS ISSUE OF SHARES, SUBSCRIPTION PERIOD FOR
WHICH WILL COMMENCE ON MONDAY 12 SEPTEMBER 2022
    * SUBSCRIPTION PRICE: SEK 1.80 PER SHARE
    * OFFERING COMPRISES MAX. 5,489,648 SHARES
    * PROVIDED THAT RIGHTS ISSUE IS FULLY SUBSCRIBED, COMPANY
WILL
RAISE ABOUT SEK 9.9 MILLION BEFORE ISSUE COSTS
    * SUBSCRIPTION PERIOD: 12 SEPTEMBER 2022 - 26 SEPTEMBER 2022

Source text for Eikon:  ID:nMFN8XRsRk 
Further company coverage:  PHARM.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))